24.11.2017
- US immunology company Dynavax has finally secured approval from the US Food and Drug Administration (FDA) for its hepatitis B vaccine. Heplisav-B is the first new vaccine to be...
24.10.2017
- The US Food and Drug Administration on Oct. 20 approved Shingrix, the long awaited recombinant, adjuvant new shingles vaccine manufactured by UK drugmaker Glaxo SmithKline (GSK)...
23.10.2017
- In a deal that could lead to the development of five new cancer vaccines, US drugs giant Eli Lilly is investing in German biopharma CureVac. Lilly will make an equity investment of...
08.09.2017
- Following all regulatory approvals, French drugmaker Sanofi has completed the acquisition of Protein Sciences, a US vaccines biotech based in Meriden, Connecticut. The deal...
26.07.2017
- US Merck’s shingles (herpes zoster) vaccine Zostavax continues to be the target of legal action at a time when the drugmaker is already facing the prospect of competition from...
13.07.2017
- French drugmaker Sanofi is gaining access to a new type of flu vaccine after agreeing to buy Protein Sciences, a privately held vaccines biotechnology company based in Meriden...
29.03.2017
- AstraZeneca’s biologics R&D arm MedImmune and Sanofi’s vaccines division Sanofi Pasteur have agreed to develop and jointly commercialize the monoclonal antibody MEDI8897 for the...
02.02.2017
- Pharmaserv Logistics, which specializes in pharmaceutical logistics, temperature-controlled exports and pre-wholesale solutions, has concluded a contract with vaccine manufacturer...
